Health
A rare clotting disorder may cloud the world’s hopes for AstraZeneca’s COVID-19 vaccine – Science Magazine
Researchers propose a mechanism and a treatment for possible deadly side effect seen in at least 30 European vaccine recipients
A man receives a dose of AstraZeneca’s COVID-19 vaccine at a conference center in Rome on 24 March. Italy halted use of the vaccine on 15 March but resumed immunizations four days later.
Antonio Masiello/Getty Images
By Kai Kupferschmidt, Gretchen VogelMar. 27, 2021 , 10:20 AM
Sciences COVID-19 reporting is supported by the Heising-Simons Foundation.
In the tumultuous rollout of AstraZeneca’s COVID-19 vaccine, all eyes were on the United States this week, where the company had a highly public communication…
-
Noosa News9 hours agoCrucial step in Sea World helicopter crash investigation set
-
Noosa News16 hours agoLocal input into new UN treaty – Proctor
-
Business14 hours agoIs the Qantas share price a buy in the tariff ASX stock market volatility?
-
General23 hours agoMan charged with attempted murder, arson and terrorism after Pennsylvania governor Josh Shapiro’s home targeted